165 related articles for article (PubMed ID: 26756563)
61. Assessment of the efficacy of bio-absorbable oxidized regenerated cellulose for prevention of post-operative pericardial adhesion in the rabbit model.
Biçer M; Bayram AS; Gürbüz O; Senkaya I; Yerci O; Tok M; Anğ E; Moğol EB; Saba D
J Int Med Res; 2008; 36(6):1311-8. PubMed ID: 19094441
[TBL] [Abstract][Full Text] [Related]
62. An appraisal of barrier agents in the reduction of adhesion formation following surgery.
Seifer DB; Diamond MP; DeCherney AH
J Gynecol Surg; 1990; 6(1):3-10. PubMed ID: 10149754
[TBL] [Abstract][Full Text] [Related]
63. Reduction of postoperative adhesions secondary to strabismus surgery in rabbits.
Yaacobi Y; Hamed LM; Kaul KS; Fanous MM
Ophthalmic Surg; 1992 Feb; 23(2):123-8. PubMed ID: 1549289
[TBL] [Abstract][Full Text] [Related]
64. Use of Interceed Absorbable Adhesion Barrier for vaginoplasty.
Jackson ND; Rosenblatt PL
Obstet Gynecol; 1994 Dec; 84(6):1048-50. PubMed ID: 7970464
[TBL] [Abstract][Full Text] [Related]
65. [The application of antiadhesive means in prevention of peritoneal commissures].
Stepanian SA; Apoian VT; Mesropian RN; Éĭramdzhian KhT; Zanadvorov LV; Petrosian AA; Egiazarian GG
Vestn Khir Im I I Grek; 2012; 171(1):45-9. PubMed ID: 22645915
[TBL] [Abstract][Full Text] [Related]
66. [Evaluation of the effectiveness of the use of various anti-adhesion agents in an experiment].
Adamian LV; Mynbaev OA; Otuo FL
Biull Eksp Biol Med; 1993 Jan; 115(1):68-9. PubMed ID: 8054585
[TBL] [Abstract][Full Text] [Related]
67. [Postoperative intra-abdominal adhesions: prevention and treatment].
Enrico S; Pecchio A; Mineccia M; Mello Teggia P
Minerva Chir; 1996 Apr; 51(4):223-6. PubMed ID: 8927271
[TBL] [Abstract][Full Text] [Related]
68. Adhesion formation after intracapsular myomectomy with or without adhesion barrier.
Tinelli A; Malvasi A; Guido M; Tsin DA; Hudelist G; Hurst B; Stark M; Mettler L
Fertil Steril; 2011 Apr; 95(5):1780-5. PubMed ID: 21256483
[TBL] [Abstract][Full Text] [Related]
69. Adhesion prevention in endometriosis: a neglected critical challenge.
Somigliana E; Vigano P; Benaglia L; Busnelli A; Vercellini P; Fedele L
J Minim Invasive Gynecol; 2012; 19(4):415-21. PubMed ID: 22575862
[TBL] [Abstract][Full Text] [Related]
70. Adhesion prevention in gynecologic surgery.
Tulandi T; Al-Shahrani A
Curr Opin Obstet Gynecol; 2005 Aug; 17(4):395-8. PubMed ID: 15976545
[TBL] [Abstract][Full Text] [Related]
71. Expanded polytetrafluoroethylene (Gore-Tex Surgical Membrane) is superior to oxidized regenerated cellulose (Interceed TC7+) in preventing adhesions.
Haney AF; Hesla J; Hurst BS; Kettel LM; Murphy AA; Rock JA; Rowe G; Schlaff WD
Fertil Steril; 1995 May; 63(5):1021-6. PubMed ID: 7720911
[TBL] [Abstract][Full Text] [Related]
72. Postoperative adhesions as a consequence of pelvic surgery.
Bolnick A; Bolnick J; Diamond MP
J Minim Invasive Gynecol; 2015; 22(4):549-63. PubMed ID: 25510980
[TBL] [Abstract][Full Text] [Related]
73. Gynecologic use of Sepraspray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study.
Fossum GT; Silverberg KM; Miller CE; Diamond MP; Holmdahl L
Fertil Steril; 2011 Aug; 96(2):487-91. PubMed ID: 21718999
[TBL] [Abstract][Full Text] [Related]
74. Clinical evaluation of the efficacy of heparin-saturated Interceed for prevention of adhesion reformation in the pelvic sidewall of the human.
Reid RL; Lie K; Spence JE; Tulandi T; Yuzpe A
Prog Clin Biol Res; 1993; 381():261-4. PubMed ID: 8316568
[No Abstract] [Full Text] [Related]
75. Assessment of the efficacy of absorbable adhesion barriers on dissection in esophagus operations.
Yilmaz O; Genc A; Taneli F; Demireli P; Deliaga H; Taneli C
Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):409-14. PubMed ID: 17161874
[TBL] [Abstract][Full Text] [Related]
76. Adhesion prevention in gynecologic surgery.
Al-Jaroudi D; Tulandi T
Obstet Gynecol Surv; 2004 May; 59(5):360-7. PubMed ID: 15097797
[TBL] [Abstract][Full Text] [Related]
77. Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: System-wide implementation and audit leads to improved value and patient outcomes.
Bisch SP; Wells T; Gramlich L; Faris P; Wang X; Tran DT; Thanh NX; Glaze S; Chu P; Ghatage P; Nation J; Capstick V; Steed H; Sabourin J; Nelson G
Gynecol Oncol; 2018 Oct; 151(1):117-123. PubMed ID: 30100053
[TBL] [Abstract][Full Text] [Related]
78. The reduction of postoperative adhesions by two different barrier methods versus control in cynomolgus monkeys: a prospective, randomized, crossover study.
Grow DR; Seltman HJ; Coddington CC; Hodgen GD
Fertil Steril; 1994 Jun; 61(6):1141-6. PubMed ID: 8194631
[TBL] [Abstract][Full Text] [Related]
79. Effect of oxidized regenerated cellulose (Interceed) on the expression of tissue plasminogen activator and plasminogen activator inhibitor-1 in human peritoneal fibroblasts and mesothelial cells.
Gago LA; Saed G; Elhammady E; Diamond MP
Fertil Steril; 2006 Oct; 86(4 Suppl):1223-7. PubMed ID: 17008148
[TBL] [Abstract][Full Text] [Related]
80. A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of Actamax™ Adhesion Barrier.
Trew GH; Pistofidis GA; Brucker SY; Krämer B; Ziegler NM; Korell M; Ritter H; McConnachie A; Ford I; Crowe AM; Estridge TD; Diamond MP; De Wilde RL
Arch Gynecol Obstet; 2017 Feb; 295(2):383-395. PubMed ID: 27844212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
